Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Brian Sauer

Concepts (390)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
42
2024
1002
6.720
 Why?
Antirheumatic Agents
24
2024
255
5.980
 Why?
Veterans
32
2023
1248
4.470
 Why?
Spondylitis, Ankylosing
5
2020
43
2.580
 Why?
Hyperkalemia
3
2023
26
2.440
 Why?
Veterans Health
8
2023
166
2.280
 Why?
United States Department of Veterans Affairs
12
2021
561
2.170
 Why?
Methotrexate
10
2021
227
1.960
 Why?
Medication Adherence
7
2019
531
1.500
 Why?
Spondylarthritis
3
2020
36
1.380
 Why?
Natural Language Processing
4
2023
72
1.380
 Why?
Registries
18
2024
1764
1.350
 Why?
Biological Products
6
2021
166
1.310
 Why?
Rheumatology
2
2020
88
1.300
 Why?
Drug-Related Side Effects and Adverse Reactions
5
2019
239
1.250
 Why?
Tumor Necrosis Factor-alpha
6
2024
1128
1.180
 Why?
Aged
46
2024
18969
1.000
 Why?
Drug Substitution
3
2021
46
1.000
 Why?
Psoriasis
2
2015
80
0.940
 Why?
Arthritis, Psoriatic
3
2019
16
0.880
 Why?
Lymphoma, Follicular
2
2021
34
0.880
 Why?
Middle Aged
47
2024
26605
0.870
 Why?
Lung Diseases, Interstitial
6
2024
495
0.850
 Why?
Humans
96
2024
114045
0.850
 Why?
Sulfasalazine
3
2019
21
0.840
 Why?
Hydroxychloroquine
3
2019
54
0.820
 Why?
United States
31
2023
12137
0.810
 Why?
Misoprostol
1
2022
18
0.800
 Why?
HLA-B27 Antigen
3
2019
11
0.790
 Why?
Electronic Health Records
6
2023
799
0.790
 Why?
Databases, Factual
7
2018
1125
0.790
 Why?
Cohort Studies
16
2024
4883
0.750
 Why?
Analgesics, Opioid
5
2020
771
0.730
 Why?
Practice Patterns, Physicians'
5
2019
1175
0.720
 Why?
Rituximab
2
2021
148
0.710
 Why?
Infliximab
3
2016
93
0.700
 Why?
Male
54
2024
55396
0.690
 Why?
Treatment Outcome
19
2024
9049
0.680
 Why?
Buprenorphine
1
2023
133
0.680
 Why?
Algorithms
5
2020
1469
0.670
 Why?
Insurance Claim Review
2
2017
68
0.670
 Why?
Pharmaceutical Services
2
2019
76
0.660
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
296
0.660
 Why?
Prostatic Neoplasms, Castration-Resistant
1
2019
40
0.650
 Why?
Severity of Illness Index
12
2023
2537
0.630
 Why?
Arthritis
2
2021
109
0.630
 Why?
Datasets as Topic
1
2019
98
0.620
 Why?
Iron
2
2021
232
0.620
 Why?
Anemia, Iron-Deficiency
1
2019
53
0.620
 Why?
Antineoplastic Agents, Immunological
1
2020
152
0.610
 Why?
Etanercept
2
2016
51
0.600
 Why?
Adalimumab
2
2016
44
0.600
 Why?
Female
49
2024
59324
0.580
 Why?
Renal Insufficiency, Chronic
2
2021
486
0.570
 Why?
Kidney Failure, Chronic
1
2022
489
0.570
 Why?
Chronic Pain
3
2022
208
0.570
 Why?
Computer Simulation
4
2020
873
0.530
 Why?
Opioid-Related Disorders
1
2023
413
0.520
 Why?
Terminology as Topic
1
2017
186
0.520
 Why?
Risk Factors
23
2024
8614
0.510
 Why?
Cross-Over Studies
1
2017
439
0.510
 Why?
Delivery of Health Care
2
2022
828
0.510
 Why?
Diabetes Mellitus
3
2024
898
0.510
 Why?
Research Design
3
2020
919
0.490
 Why?
Healthcare Common Procedure Coding System
1
2014
2
0.480
 Why?
Cytokines
5
2024
1824
0.460
 Why?
Hospitalization
5
2021
1762
0.460
 Why?
Insurance, Pharmaceutical Services
2
2011
23
0.460
 Why?
Adipokines
3
2022
42
0.460
 Why?
Models, Statistical
2
2017
595
0.440
 Why?
Ambulatory Care
2
2014
479
0.440
 Why?
Narcotics
1
2013
44
0.430
 Why?
Emergency Service, Hospital
3
2023
1815
0.420
 Why?
Comparative Effectiveness Research
1
2013
131
0.410
 Why?
Health Services Accessibility
2
2019
756
0.410
 Why?
Utah
7
2013
59
0.400
 Why?
Potassium
2
2023
127
0.400
 Why?
Drug Prescriptions
2
2013
237
0.400
 Why?
Remission Induction
3
2022
233
0.400
 Why?
Time Factors
11
2021
6077
0.390
 Why?
Decision Support Systems, Clinical
2
2012
175
0.390
 Why?
Medicine
1
2013
102
0.390
 Why?
Pharmaceutical Preparations
3
2022
164
0.390
 Why?
Proportional Hazards Models
8
2022
1078
0.380
 Why?
Drug Overdose
2
2012
292
0.380
 Why?
Cardiovascular Diseases
8
2023
1726
0.380
 Why?
Retrospective Studies
18
2023
12521
0.370
 Why?
Disease Progression
2
2018
2371
0.370
 Why?
Carpal Bones
2
2021
14
0.370
 Why?
Inflammatory Bowel Diseases
1
2015
284
0.360
 Why?
Practice Guidelines as Topic
2
2019
1381
0.350
 Why?
Adiponectin
4
2024
213
0.340
 Why?
Potentially Inappropriate Medication List
2
2020
14
0.340
 Why?
Aged, 80 and over
13
2021
6306
0.330
 Why?
Quality Indicators, Health Care
1
2012
285
0.330
 Why?
C-Reactive Protein
4
2021
362
0.330
 Why?
Body Mass Index
6
2018
1957
0.330
 Why?
Risk Assessment
10
2021
2958
0.320
 Why?
Prospective Studies
9
2024
6195
0.310
 Why?
Kaplan-Meier Estimate
3
2021
813
0.310
 Why?
Incidence
9
2024
2314
0.300
 Why?
Antibodies, Monoclonal
1
2014
1257
0.300
 Why?
Health Knowledge, Attitudes, Practice
2
2013
1168
0.300
 Why?
Pneumonia, Bacterial
2
2020
103
0.290
 Why?
ROC Curve
3
2019
441
0.290
 Why?
International Classification of Diseases
4
2023
116
0.280
 Why?
Multimorbidity
2
2023
32
0.270
 Why?
Predictive Value of Tests
4
2020
1791
0.270
 Why?
Adult
16
2022
30375
0.260
 Why?
Managed Care Programs
1
2007
133
0.260
 Why?
Propensity Score
3
2020
225
0.260
 Why?
Arthrodesis
3
2021
104
0.250
 Why?
Drug Utilization
2
2018
164
0.250
 Why?
Drug Therapy, Combination
2
2019
949
0.250
 Why?
Patient Admission
1
2007
175
0.240
 Why?
Embryo, Nonmammalian
2
2005
173
0.240
 Why?
Neoplasms
5
2023
2086
0.230
 Why?
Gene Targeting
1
2004
75
0.230
 Why?
Alarmins
1
2024
24
0.230
 Why?
Data Mining
3
2023
100
0.230
 Why?
Interleukin-33
1
2024
38
0.230
 Why?
Regression Analysis
3
2018
945
0.230
 Why?
Embryo, Mammalian
1
2004
213
0.220
 Why?
Wrist
2
2021
47
0.220
 Why?
Weight Loss
2
2018
642
0.220
 Why?
Follow-Up Studies
7
2021
4392
0.220
 Why?
Wrist Joint
2
2021
59
0.210
 Why?
Poisson Distribution
2
2017
71
0.210
 Why?
Stroke
2
2021
1019
0.210
 Why?
Comorbidity
4
2023
1447
0.200
 Why?
Rheumatic Diseases
1
2023
49
0.200
 Why?
Diclofenac
1
2022
14
0.200
 Why?
Blood Sedimentation
2
2019
32
0.200
 Why?
Chemokines
2
2021
215
0.200
 Why?
Research Report
1
2022
75
0.200
 Why?
Genetic Testing
1
2004
381
0.190
 Why?
Confidence Intervals
2
2016
302
0.190
 Why?
Polymerase Chain Reaction
1
2004
990
0.190
 Why?
Linear Models
3
2018
768
0.190
 Why?
Waldenstrom Macroglobulinemia
1
2021
11
0.180
 Why?
Multivariate Analysis
5
2018
1422
0.180
 Why?
Hospitals, Veterans
3
2018
244
0.180
 Why?
Maintenance Chemotherapy
1
2020
22
0.180
 Why?
Arthritis, Infectious
1
2021
49
0.170
 Why?
Cyclophosphamide
2
2021
214
0.170
 Why?
Stem Cells
1
2004
541
0.170
 Why?
Prosthesis-Related Infections
1
2021
70
0.170
 Why?
Prescription Drugs
2
2012
116
0.170
 Why?
Pneumonia, Staphylococcal
1
2020
14
0.170
 Why?
Neoplasm Grading
1
2020
241
0.170
 Why?
SEER Program
1
2020
195
0.170
 Why?
Bipolar Disorder
1
2021
203
0.170
 Why?
Arthroplasty, Replacement, Hip
1
2021
107
0.160
 Why?
Transferrin
1
2019
39
0.160
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
97
0.160
 Why?
Ferritins
1
2019
52
0.160
 Why?
Inappropriate Prescribing
1
2019
52
0.160
 Why?
Coronary Artery Disease
2
2022
611
0.160
 Why?
Geriatrics
1
2019
69
0.160
 Why?
Ranolazine
1
2018
22
0.160
 Why?
Methicillin-Resistant Staphylococcus aureus
2
2020
192
0.160
 Why?
Longitudinal Studies
4
2023
2384
0.150
 Why?
Angina, Stable
1
2018
17
0.150
 Why?
Drug Monitoring
2
2012
184
0.150
 Why?
Heart Failure
2
2021
1958
0.150
 Why?
Feasibility Studies
2
2020
735
0.150
 Why?
Area Under Curve
1
2019
273
0.150
 Why?
Anti-Citrullinated Protein Antibodies
1
2019
90
0.150
 Why?
Osteoarthritis
1
2020
169
0.150
 Why?
Calcium Channel Blockers
1
2018
113
0.150
 Why?
Communication
1
2023
734
0.150
 Why?
Rheumatologists
1
2017
12
0.150
 Why?
Professional Practice Location
1
2017
26
0.150
 Why?
Brain Ischemia
1
2021
297
0.150
 Why?
Random Allocation
1
2018
328
0.140
 Why?
Sacroiliitis
1
2017
3
0.140
 Why?
Population Surveillance
2
2012
385
0.140
 Why?
Neoplasm Metastasis
1
2019
521
0.140
 Why?
Prognosis
3
2020
3315
0.140
 Why?
Recovery of Function
1
2021
573
0.140
 Why?
Obesity, Abdominal
1
2017
37
0.140
 Why?
Reverse Transcriptase Inhibitors
1
2018
82
0.140
 Why?
Precision Medicine
1
2020
335
0.140
 Why?
Data Accuracy
1
2017
48
0.140
 Why?
Arthroplasty, Replacement, Knee
1
2021
246
0.140
 Why?
Hypertension
2
2018
1052
0.140
 Why?
Protease Inhibitors
1
2018
96
0.140
 Why?
Bias
3
2013
178
0.140
 Why?
Cross-Sectional Studies
6
2024
4402
0.140
 Why?
Leptin
3
2022
210
0.140
 Why?
Neoplasm Staging
1
2020
1162
0.140
 Why?
Disability Evaluation
1
2018
271
0.140
 Why?
HIV Integrase Inhibitors
1
2018
62
0.140
 Why?
Adverse Drug Reaction Reporting Systems
2
2007
68
0.140
 Why?
Forecasting
1
2018
331
0.140
 Why?
Travel
1
2017
121
0.140
 Why?
Risk Management
2
2007
89
0.140
 Why?
Pain
1
2022
701
0.140
 Why?
Anti-Inflammatory Agents
2
2018
445
0.130
 Why?
Dose-Response Relationship, Radiation
1
2016
127
0.130
 Why?
Adrenergic beta-Antagonists
1
2018
286
0.130
 Why?
Antimicrobial Stewardship
1
2018
92
0.130
 Why?
Cyclosporine
1
2016
161
0.130
 Why?
Obesity
2
2018
2505
0.130
 Why?
Hospital Mortality
1
2020
773
0.130
 Why?
Observational Studies as Topic
1
2016
90
0.130
 Why?
Fees, Pharmaceutical
1
2015
13
0.130
 Why?
Anti-Retroviral Agents
1
2018
207
0.130
 Why?
Drug Administration Routes
1
2015
38
0.130
 Why?
Anti-Infective Agents
1
2018
219
0.130
 Why?
Pseudomonas Infections
1
2017
184
0.130
 Why?
Suicide
1
2021
507
0.130
 Why?
Cause of Death
4
2023
362
0.130
 Why?
Logistic Models
2
2018
1829
0.120
 Why?
Cross Infection
1
2017
194
0.120
 Why?
Quality Improvement
1
2022
944
0.120
 Why?
Health Care Costs
1
2018
381
0.120
 Why?
Recombination, Genetic
3
2005
176
0.120
 Why?
Inflammation Mediators
1
2017
475
0.120
 Why?
Drug Administration Schedule
1
2016
714
0.120
 Why?
Glucocorticoids
1
2018
526
0.110
 Why?
Guideline Adherence
1
2018
489
0.110
 Why?
Health Expenditures
1
2015
172
0.110
 Why?
Telemedicine
1
2022
662
0.110
 Why?
HIV Infections
2
2018
2453
0.110
 Why?
Infusions, Intravenous
1
2014
370
0.110
 Why?
Prednisone
3
2021
229
0.110
 Why?
Causality
1
2013
104
0.110
 Why?
Socioeconomic Factors
2
2018
1080
0.110
 Why?
Adiposity
1
2017
458
0.110
 Why?
Mortality
1
2015
283
0.110
 Why?
Pneumonia
1
2018
563
0.100
 Why?
Integrases
3
2005
116
0.100
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
35
0.100
 Why?
Feedback
2
2023
144
0.100
 Why?
Education, Medical, Continuing
1
2013
115
0.100
 Why?
Lung Neoplasms
2
2022
2159
0.100
 Why?
Root Cause Analysis
1
2012
8
0.100
 Why?
HIV-1
1
2018
768
0.100
 Why?
Prescription Drug Misuse
1
2012
38
0.100
 Why?
Lung Diseases
1
2018
690
0.100
 Why?
Florida
1
2012
73
0.100
 Why?
Adolescent
5
2015
17800
0.100
 Why?
Health Personnel
1
2017
569
0.100
 Why?
Occupational Injuries
1
2012
46
0.100
 Why?
Outpatients
1
2014
325
0.100
 Why?
Narration
1
2012
44
0.090
 Why?
Antineoplastic Agents
1
2022
1875
0.090
 Why?
Internal Medicine
1
2013
211
0.090
 Why?
Reproducibility of Results
2
2016
2764
0.090
 Why?
Osteoporotic Fractures
1
2012
54
0.090
 Why?
Risk
1
2013
810
0.090
 Why?
Anti-Bacterial Agents
1
2020
1471
0.090
 Why?
Substance-Related Disorders
2
2023
942
0.090
 Why?
Young Adult
3
2015
10444
0.090
 Why?
Dose-Response Relationship, Drug
1
2014
1836
0.090
 Why?
Blood Pressure
2
2018
1531
0.080
 Why?
Sex Factors
3
2021
1706
0.080
 Why?
Machine Learning
2
2022
315
0.080
 Why?
Referral and Consultation
1
2013
632
0.080
 Why?
Pattern Recognition, Automated
1
2008
67
0.080
 Why?
Biomarkers
3
2024
3397
0.080
 Why?
Diagnosis, Computer-Assisted
1
2008
64
0.080
 Why?
Catheter-Related Infections
1
2008
61
0.070
 Why?
Hospital Records
1
2007
10
0.070
 Why?
Cost Sharing
1
2007
14
0.070
 Why?
Antihypertensive Agents
1
2011
428
0.070
 Why?
Financing, Personal
1
2007
24
0.070
 Why?
Artificial Intelligence
1
2008
144
0.070
 Why?
Nonlinear Dynamics
1
2007
81
0.070
 Why?
Viral Proteins
2
1999
281
0.070
 Why?
Insulin-Like Growth Factor I
2
1999
286
0.070
 Why?
Primary Health Care
2
2013
1502
0.070
 Why?
Mutagenesis, Site-Directed
2
2005
345
0.070
 Why?
Drug Interactions
1
2007
337
0.060
 Why?
Respiratory Tract Diseases
2
2017
139
0.060
 Why?
Mass Screening
1
2012
979
0.060
 Why?
Models, Theoretical
1
2008
513
0.060
 Why?
Chronic Disease
2
2022
1577
0.060
 Why?
Mental Disorders
1
2012
889
0.060
 Why?
Health Services Research
1
2007
373
0.060
 Why?
Blotting, Southern
1
2004
68
0.060
 Why?
Data Collection
1
2007
618
0.060
 Why?
Myocardial Infarction
1
2011
932
0.060
 Why?
Interleukin-17
1
2024
104
0.060
 Why?
Health Status
2
2018
716
0.050
 Why?
Vital Capacity
1
2023
254
0.050
 Why?
Length of Stay
1
2007
957
0.050
 Why?
Odds Ratio
2
2018
951
0.050
 Why?
Acetazolamide
1
2022
30
0.050
 Why?
Telomere Shortening
1
2022
17
0.050
 Why?
Medicare
1
2007
661
0.050
 Why?
Antimanic Agents
1
2021
14
0.050
 Why?
Lithium
1
2021
36
0.050
 Why?
Valproic Acid
1
2021
43
0.050
 Why?
Zebrafish
1
2005
413
0.050
 Why?
Patient Discharge
2
2023
770
0.050
 Why?
Chlorambucil
1
2021
8
0.050
 Why?
Medication Therapy Management
1
2022
67
0.050
 Why?
Vidarabine
1
2021
26
0.050
 Why?
Bendamustine Hydrochloride
1
2021
11
0.050
 Why?
Bortezomib
1
2021
41
0.050
 Why?
Magnetic Resonance Imaging
2
2022
3039
0.050
 Why?
Pulmonologists
1
2020
13
0.050
 Why?
Vincristine
1
2021
98
0.040
 Why?
Data Display
1
2020
19
0.040
 Why?
Cerebrovascular Circulation
1
2022
219
0.040
 Why?
Telomere
1
2022
202
0.040
 Why?
Computed Tomography Angiography
1
2021
100
0.040
 Why?
Quality Control
1
2020
143
0.040
 Why?
Pharmacists
1
2022
231
0.040
 Why?
Doxorubicin
1
2021
286
0.040
 Why?
Piperidines
1
2021
159
0.040
 Why?
User-Computer Interface
1
2020
141
0.040
 Why?
Bone Marrow Transplantation
1
2020
237
0.040
 Why?
Range of Motion, Articular
1
2021
350
0.040
 Why?
Embryonic and Fetal Development
1
1999
94
0.040
 Why?
Magnetic Resonance Angiography
1
2021
221
0.040
 Why?
Adenine
1
2021
218
0.040
 Why?
Dexamethasone
1
2021
316
0.040
 Why?
Patient Satisfaction
1
2022
571
0.040
 Why?
Time-to-Treatment
1
2019
146
0.040
 Why?
Reoperation
1
2020
513
0.040
 Why?
Cost-Benefit Analysis
1
2020
544
0.040
 Why?
Infant Mortality
1
1998
91
0.040
 Why?
Gene Dosage
1
1998
129
0.040
 Why?
Recurrence
1
2020
925
0.040
 Why?
Methicillin Resistance
1
2017
19
0.040
 Why?
Gene Expression Regulation, Developmental
2
1999
801
0.040
 Why?
Critical Illness
1
2022
640
0.040
 Why?
Cardiovascular Agents
1
2018
125
0.040
 Why?
HIV Integrase
1
2018
67
0.030
 Why?
Rheumatic Nodule
1
2016
3
0.030
 Why?
Absorptiometry, Photon
1
2017
224
0.030
 Why?
Nutrition Surveys
1
2017
225
0.030
 Why?
Isoxazoles
1
2016
51
0.030
 Why?
Thinness
1
2016
87
0.030
 Why?
Viral Load
1
2018
405
0.030
 Why?
Body Weight
2
2016
868
0.030
 Why?
Community-Acquired Infections
1
2017
139
0.030
 Why?
Surveys and Questionnaires
2
2020
4595
0.030
 Why?
Lymphoma
1
2016
176
0.030
 Why?
Rheumatoid Factor
1
2016
157
0.030
 Why?
Survival Analysis
1
2018
1206
0.030
 Why?
Analysis of Variance
1
2018
1218
0.030
 Why?
Peptides, Cyclic
1
2016
252
0.030
 Why?
Leukemia
1
2016
208
0.030
 Why?
Tomography, X-Ray Computed
1
2023
2272
0.030
 Why?
Age Factors
1
2021
2885
0.030
 Why?
Quality of Health Care
1
2018
572
0.030
 Why?
Life Style
1
2016
428
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1356
0.030
 Why?
Workers' Compensation
1
2012
27
0.030
 Why?
Inflammation
1
2022
2464
0.030
 Why?
Coroners and Medical Examiners
1
2011
6
0.020
 Why?
Death Certificates
1
2011
30
0.020
 Why?
Sampling Studies
1
2011
92
0.020
 Why?
Brain
1
2022
2355
0.020
 Why?
Pancreatic Neoplasms
1
2016
721
0.020
 Why?
Prostatic Neoplasms
1
2016
913
0.020
 Why?
Smoking
1
2016
1382
0.020
 Why?
Quality of Life
1
2019
2343
0.020
 Why?
Child
1
2007
18401
0.020
 Why?
Medical Assistance
1
2007
13
0.020
 Why?
Deductibles and Coinsurance
1
2007
9
0.020
 Why?
Models, Econometric
1
2007
34
0.020
 Why?
Psychoses, Substance-Induced
1
2007
12
0.020
 Why?
Inpatients
1
2011
378
0.020
 Why?
Eligibility Determination
1
2007
59
0.020
 Why?
Evidence-Based Medicine
1
2011
662
0.020
 Why?
Costs and Cost Analysis
1
2007
196
0.020
 Why?
Delirium
1
2007
66
0.020
 Why?
Insurance Coverage
1
2007
199
0.020
 Why?
Blood Coagulation Disorders
1
2007
154
0.020
 Why?
beta-Galactosidase
1
2005
62
0.020
 Why?
HSP70 Heat-Shock Proteins
1
2005
61
0.020
 Why?
Mosaicism
1
2005
62
0.020
 Why?
Genes, Reporter
1
2005
256
0.010
 Why?
Animals, Genetically Modified
1
2005
215
0.010
 Why?
Sensitivity and Specificity
1
2008
1690
0.010
 Why?
Case-Control Studies
1
2011
3003
0.010
 Why?
Mice, Transgenic
2
1999
1947
0.010
 Why?
Hemorrhage
1
2007
600
0.010
 Why?
Recombinant Fusion Proteins
1
2005
613
0.010
 Why?
Liver
2
1999
1633
0.010
 Why?
Growth Disorders
1
1998
77
0.010
 Why?
Animals
3
2005
31565
0.010
 Why?
Mice
2
1999
14843
0.010
 Why?
RNA, Messenger
1
1998
2550
0.010
 Why?
Infant, Newborn
1
1998
5038
0.000
 Why?
Sauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (390) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)